Emkay Global Financial Services Ltd - 532737 - Shareholding for the Period Ended March 31, 2021
Emkay Global Financial Services Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
Emkay in tie-up with Stockal
Emkay Global Financial Services has tied up with Stockal - a global investment platform to help its clients invest in US-listed stocks and securities.
Emkay Global ties up with Stockal: Now, you can invest in US-listed stocks
Through the association of Emkay and Stockal, clients will be provided access to thematic investments that are available in the US equity market Broker's call: HDFC Bank (Buy)
Emkay GlobalHDFC Bank (Buy)Target: 1,850CMP: 1440.95HDFC Bank has reported a loan growth of 14 per cent y-o-y/5 per cent q-o-q at 11.3 lakh crore, Emkay Global Financial Services Ltd - 532737 - Closure of Trading Window
Intimation of closure of Trading Window pursuant to provisions of SEBI (Prohibition of Insider Trading Regulations, 2015 Broker's Call: Cadila Health (Buy)
Emkay GlobalTarget: 665CMP: 420Cadila announced the settlement of Revlimid patent suit with the innovator Celgene (BMS). As part of the settlement,
Buy Cadila Healthcare; target of Rs 655: Emkay Global Financial
Emkay Global Financial is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 655 in its research report dated March 24, 2021. Emkay Global Financial Services Ltd - 532737 - Announcement under Regulation 30 (LODR)-Meeting Updates
Outcome of Independent Director''s meeting held on 19.03.2021 Well run mid- and small-caps seeing strong growth: Emkay Investment CEO
Global interest rates are likely to remain benign for long, says Vikaas Sachdeva in interview.
Buy Westlife Development; target of Rs 600: Emkay Global Financial
Emkay Global Financial is bullish on Westlife Development has recommended buy rating on the stock with a target price of Rs 600 in its research report dated March 17, 2021.